Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Outcomes of kidney transplantation in HIV-infected recipients.

Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME.

N Engl J Med. 2010 Nov 18;363(21):2004-14. doi: 10.1056/NEJMoa1001197. Erratum in: N Engl J Med. 2011 Mar 17;364(11):1082.

2.

Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(4):1-56. Epub 2010 Mar 1.

3.

Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients.

Carter JT, Melcher ML, Carlson LL, Roland ME, Stock PG.

Am J Transplant. 2006 Apr;6(4):753-60.

4.

Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.

Locke JE, James NT, Mannon RB, Mehta SG, Pappas PG, Baddley JW, Desai NM, Montgomery RA, Segev DL.

Transplantation. 2014 Feb 27;97(4):446-50. doi: 10.1097/01.TP.0000436905.54640.8c.

PMID:
24162248
5.

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.

Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL.

Transplantation. 2003 Jul 27;76(2):370-5.

PMID:
12883195
6.

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.

Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG.

Am J Transplant. 2008 Feb;8(2):355-65. Epub 2007 Dec 18. Erratum in: Am J Transplant.2008 May;8(5): 1081.

7.

Kidney transplantation in HIV-positive adults: the UK experience.

Gathogo EN, Hamzah L, Hilton R, Marshall N, Ashley C, Harber M, Levy JB, Jones R, Boffito M, Khoo SH, Drage M, Bhagani S, Post FA; UK HIV/Kidney Transplantation Study Group (see appendix).

Int J STD AIDS. 2014 Jan;25(1):57-66. doi: 10.1177/0956462413493266. Epub 2013 Jul 19.

PMID:
23970634
8.

HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles.

Muthukumar T, Afaneh C, Ding R, Tsapepas D, Lubetzky M, Jacobs S, Lee J, Sharma V, Lee J, Dadhania D, Hartono C, McDermott J, Aull M, Leeser D, Kapur S, Serur D, Suthanthiran M.

Transplantation. 2013 Mar 15;95(5):711-20. doi: 10.1097/TP.0b013e31827ac322.

9.

Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.

Gathogo E, Harber M, Bhagani S, Levy J, Jones R, Hilton R, Davies G, Post FA; UK HIV Kidney Transplantation Study Group.

Transplantation. 2016 Apr;100(4):871-8. doi: 10.1097/TP.0000000000000879.

PMID:
26413990
10.

[Renal transplantation in HIV-infected patients in Spain].

Mazuecos A, Pascual J, Gómez E, Sola E, Cofán F, López F, Puig-Hooper CE, Baltar JM, González-Molina M, Oppenheimer F, Marcén R, Rivero M.

Nefrologia. 2006;26(1):113-20. Spanish.

11.

Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.

Kumar MS, Sierka DR, Damask AM, Fyfe B, McAlack RF, Heifets M, Moritz MJ, Alvarez D, Kumar A.

Kidney Int. 2005 Apr;67(4):1622-9.

12.

High incidence of delayed graft function in HIV-infected kidney transplant recipients.

Mazuecos A, Fernandez A, Zarraga S, Andres A, Rodriguez-Benot A, Jimenez C, Gomez E, Paul J, Jimeno L, Fernandez C, Burgos D, Sanchez-Fructuoso A, Guirado L.

Transpl Int. 2013 Sep;26(9):893-902. doi: 10.1111/tri.12147. Epub 2013 Jul 11.

13.

Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.

Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, Sun X, Chen J, Yang S, Cai J, Gao X, Pileggi A, Ricordi C.

JAMA. 2012 Mar 21;307(11):1169-77. doi: 10.1001/jama.2012.316.

PMID:
22436957
14.

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.

Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2012 Jun;18(6):716-26. doi: 10.1002/lt.23411.

15.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X.

N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.

16.

HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years.

Muller E, Barday Z, Mendelson M, Kahn D.

N Engl J Med. 2015 Feb 12;372(7):613-20. doi: 10.1056/NEJMoa1408896.

17.

High frequency of rejections in HIV-positive recipients of kidney transplantation: a single center prospective trial.

Malat GE, Ranganna KM, Sikalas N, Liu L, Jindal RM, Doyle A.

Transplantation. 2012 Nov 27;94(10):1020-4. doi: 10.1097/TP.0b013e31826c3947.

PMID:
23169224
18.

CD4+ count-guided interruption of antiretroviral treatment.

Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fätkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C.

N Engl J Med. 2006 Nov 30;355(22):2283-96.

19.

Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.

Luan FL, Schaubel DE, Zhang H, Jia X, Pelletier SJ, Port FK, Magee JC, Sung RS.

Transplantation. 2008 Jun 15;85(11):1601-6. doi: 10.1097/TP.0b013e3181722f3a.

PMID:
18551066
20.

A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.

Stevens RB, Foster KW, Miles CD, Lane JT, Kalil AC, Florescu DF, Sandoz JP, Rigley TH, Nielsen KJ, Skorupa JY, Kellogg AM, Malik T, Wrenshall LE.

Transplantation. 2015 Jan;99(1):197-209. doi: 10.1097/TP.0000000000000250.

Supplemental Content

Support Center